1. A. The licensee shall ensure that:

   1. 1. The requirements in subsection (B) and the patient rights in subsection (C) are conspicuously posted on the premises;
   2. 2. At the time of admission, a patient or the patient’s representative receives a written copy of the requirements in subsection (B) and the patient rights in subsection (C); and

   3. 3. Policies and procedures are established, documented, and implemented to protect the health and safety of a patient that include:

      1. a. How and when a patient or the patient’s representative is informed of patient rights in subsection (C); and
      2. b. Where patient rights are posted as required in subsection (A)(1).

2. B. A licensee shall ensure that:

   1. 1. A patient is treated with dignity, respect, and consideration;

   2. 2. A patient is not subjected to:

      1. a. Abuse;
      2. b. Neglect;
      3. c. Exploitation;
      4. d. Coercion;
      5. e. Manipulation;
      6. f. Sexual abuse;
      7. g. Sexual assault;
      8. h. Retaliation for submitting a complaint to the Department or another entity; or
      9. i. Misappropriation of personal and private property by a pain management clinic's personnel member, employee, volunteer, or student; and

   3. 3. A patient or the patient’s representative:

      1. a. Except in an emergency, either consents to or refuses treatment;
      2. b. May refuse or withdraw consent for treatment before treatment is initiated;

      3. c. Is informed of the following:

         1. i. The pain management clinic’s policy on health care directives, and
         2. ii. The patient complaint process;
      4. d. Consents to photographs of the patient before a patient is photographed, except that a patient may be photographed when admitted to a pain management clinic for identification and administrative purposes; and

      5. e. Except as otherwise permitted by law, provides written consent to the release of information in the patient’s:

         1. i. Medical record, or
         2. ii. Financial records.

3. C. A patient has the following rights:

   1. 1. Not to be discriminated against based on race, national origin, religion, gender, sexual orientation, age, disability, marital status, or diagnosis;
   2. 2. To receive treatment that supports and respects the patient’s individuality, choices, strengths, and abilities;
   3. 3. To receive privacy in treatment and care for personal needs;
   4. 4. To review, upon written request, the patient’s own medical record according to A.R.S. §§ 12-2293, 12-2294, and 12-2294.01;
   5. 5. To receive a referral to another health care institution if the pain management clinic is not authorized or not able to provide rehabilitation services or counseling services needed by the patient;
   6. 6. To participate or have the patient’s representative participate in the development of, or decisions concerning, treatment;
   7. 7. To participate or refuse to participate in research or experimental treatment; and
   8. 8. To receive assistance from a family member, the patient’s representative, or other individual in understanding, protecting, or exercising the patient’s rights.

4. D. A medical director shall ensure that before an opioid is prescribed or ordered for a patient, a medical practitioner obtains informed consent from the patient or patient’s representative that includes:

   1. 1. The patient’s:

      1. a. Name,
      2. b. Date of birth or other patient identifier, and
      3. c. Condition for which an opioid is being prescribed or ordered;
   2. 2. That an opioid is being prescribed or ordered;
   3. 3. The potential risks, adverse reactions, complications, and medication interactions associated with the use of an opioid;
   4. 4. If applicable, the potential risks, adverse outcomes, and complications associated with the concurrent use of an opioid and a benzodiazepine or another sedative-hypnotic medication;
   5. 5. Alternatives to a prescribed or ordered opioid;
   6. 6. The name and signature of the individual explaining the use of an opioid to the patient; and
   7. 7. The signature of the patient or the patient’s representative and the date signed.

Historical Note

New Section made by final rulemaking at 24 A.A.R. 3020, effective January 1, 2019 (Supp. 18-4). Section R9-10-2005 renumbered to R9-10-2007; new Section R9-10-2005 renumbered from R9-10-2007 and amended by final rulemaking at 32 A.A.R. 504 (February 27, 2026, Issue 9), effective April 6, 2026 (Supp. 26-1).